Objectives: The identification of reliable non-invasive biomarkers of Crohn disease (CD) activity is crucial. Fecal calprotectin (FC) is the most promising one. We aimed to define whether its performance for isolated ileal CD could be as useful as for colonic and ileocolonic disease.Methods: Retrospective observational study of all pediatric patients affected with CD with FC and inflammatory blood markers performed within one week from an ileocolonoscopy or magnetic resonance enterography. The sensitivity, specificity, negative predictive value, positive predictive value and accuracy of FC >50 mcg/g were evaluated for isolated ileal CD (L1), colonic CD (L2) and ilecolonic CD (L3) using ilecolonoscopy and magnetic resonance enterography as the reference standard. The best FC cut-off for each disease location was evaluated using receiver operating characteristic curves.Results: One-hundred seventy-six FC measurements from a total of 98 patients were collected (14.3% L1, 10.2% L2, 75.5% L3). The sensitivity and specificity of FC for Ll CD were 36% and 91%, respectively, compared to 93% and 75% for L2 and 70% and 95% for L3. An FC of 95 mg/kg was identified as the best cut off for identification of active isolated ileal disease, with a sensitivity of 77% and a specificity of 56% [area under the curve (confidence interval [CI] 0.56- 0.97) 0.77, P = 0.02].Conclusions: With a sensitivity of 36%, FC alone does not accurately reflect isolated Ll disease activity. A significantly lower threshold should be applied for increasing its performance for isolated small bowel CD monitoring.

Is fecal calprotectin a useful marker for small bowel Crohn's disease? / D'Arcangelo, Giulia; Imondi, Chiara; Terrin, Gianluca; Catassi, Giulia; Aloi, Marina. - In: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. - ISSN 0277-2116. - 73:2(2021), pp. 242-246. [10.1097/MPG.0000000000003151]

Is fecal calprotectin a useful marker for small bowel Crohn's disease?

D'Arcangelo, Giulia;Imondi, Chiara;Terrin, Gianluca;Aloi, Marina
2021

Abstract

Objectives: The identification of reliable non-invasive biomarkers of Crohn disease (CD) activity is crucial. Fecal calprotectin (FC) is the most promising one. We aimed to define whether its performance for isolated ileal CD could be as useful as for colonic and ileocolonic disease.Methods: Retrospective observational study of all pediatric patients affected with CD with FC and inflammatory blood markers performed within one week from an ileocolonoscopy or magnetic resonance enterography. The sensitivity, specificity, negative predictive value, positive predictive value and accuracy of FC >50 mcg/g were evaluated for isolated ileal CD (L1), colonic CD (L2) and ilecolonic CD (L3) using ilecolonoscopy and magnetic resonance enterography as the reference standard. The best FC cut-off for each disease location was evaluated using receiver operating characteristic curves.Results: One-hundred seventy-six FC measurements from a total of 98 patients were collected (14.3% L1, 10.2% L2, 75.5% L3). The sensitivity and specificity of FC for Ll CD were 36% and 91%, respectively, compared to 93% and 75% for L2 and 70% and 95% for L3. An FC of 95 mg/kg was identified as the best cut off for identification of active isolated ileal disease, with a sensitivity of 77% and a specificity of 56% [area under the curve (confidence interval [CI] 0.56- 0.97) 0.77, P = 0.02].Conclusions: With a sensitivity of 36%, FC alone does not accurately reflect isolated Ll disease activity. A significantly lower threshold should be applied for increasing its performance for isolated small bowel CD monitoring.
2021
fecal calprotectin; marker; small bowel; Crohn disease
01 Pubblicazione su rivista::01a Articolo in rivista
Is fecal calprotectin a useful marker for small bowel Crohn's disease? / D'Arcangelo, Giulia; Imondi, Chiara; Terrin, Gianluca; Catassi, Giulia; Aloi, Marina. - In: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. - ISSN 0277-2116. - 73:2(2021), pp. 242-246. [10.1097/MPG.0000000000003151]
File allegati a questo prodotto
File Dimensione Formato  
DArcangelo_Fecal-calprotectin_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 259.46 kB
Formato Adobe PDF
259.46 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1566088
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
social impact